TALPHERA INC (TLPH) Stock Fundamental Analysis

NASDAQ:TLPH • US00444T2096

0.8123 USD
0 (-0.05%)
At close: Feb 12, 2026
0.8 USD
-0.01 (-1.51%)
After Hours: 2/12/2026, 8:18:24 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, TLPH scores 2 out of 10 in our fundamental rating. TLPH was compared to 191 industry peers in the Pharmaceuticals industry. While TLPH seems to be doing ok healthwise, there are quite some concerns on its profitability. TLPH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • TLPH had negative earnings in the past year.
  • In the past year TLPH has reported a negative cash flow from operations.
  • TLPH had negative earnings in 4 of the past 5 years.
  • In the past 5 years TLPH always reported negative operating cash flow.
TLPH Yearly Net Income VS EBIT VS OCF VS FCFTLPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

  • TLPH's Return On Assets of -40.30% is in line compared to the rest of the industry. TLPH outperforms 43.98% of its industry peers.
  • With a Return On Equity value of -64.60%, TLPH perfoms like the industry average, outperforming 45.55% of the companies in the same industry.
Industry RankSector Rank
ROA -40.3%
ROE -64.6%
ROIC N/A
ROA(3y)-24.13%
ROA(5y)-35.67%
ROE(3y)-32.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TLPH Yearly ROA, ROE, ROICTLPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

  • With an excellent Gross Margin value of 12540700.00%, TLPH belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • TLPH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12540700%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TLPH Yearly Profit, Operating, Gross MarginsTLPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200K 400K 600K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • TLPH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TLPH has more shares outstanding than it did 1 year ago.
  • TLPH has more shares outstanding than it did 5 years ago.
  • TLPH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TLPH Yearly Shares OutstandingTLPH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
TLPH Yearly Total Debt VS Total AssetsTLPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • TLPH has an Altman-Z score of -20.00. This is a bad value and indicates that TLPH is not financially healthy and even has some risk of bankruptcy.
  • TLPH has a worse Altman-Z score (-20.00) than 83.25% of its industry peers.
  • TLPH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -20
ROIC/WACCN/A
WACC9.27%
TLPH Yearly LT Debt VS Equity VS FCFTLPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

  • TLPH has a Current Ratio of 6.83. This indicates that TLPH is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 6.83, TLPH is doing good in the industry, outperforming 69.63% of the companies in the same industry.
  • A Quick Ratio of -1.30 indicates that TLPH may have some problems paying its short term obligations.
  • TLPH's Quick ratio of -1.30 is on the low side compared to the rest of the industry. TLPH is outperformed by 96.86% of its industry peers.
Industry RankSector Rank
Current Ratio 6.83
Quick Ratio -1.3
TLPH Yearly Current Assets VS Current LiabilitesTLPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 44.93% over the past year.
  • The Revenue for TLPH has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)44.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 20.30% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y30%
EPS Next 2Y14.02%
EPS Next 3Y6.27%
EPS Next 5Y20.3%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TLPH Yearly Revenue VS EstimatesTLPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
TLPH Yearly EPS VS EstimatesTLPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 5 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TLPH. In the last year negative earnings were reported.
  • Also next year TLPH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLPH Price Earnings VS Forward Price EarningsTLPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TLPH is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.52
TLPH Per share dataTLPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.02%
EPS Next 3Y6.27%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TLPH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TALPHERA INC

NASDAQ:TLPH (2/12/2026, 8:18:24 PM)

After market: 0.8 -0.01 (-1.51%)

0.8123

0 (-0.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12
Earnings (Next)03-05
Inst Owners31.69%
Inst Owner ChangeN/A
Ins Owners8.9%
Ins Owner Change0.33%
Market Cap37.86M
Revenue(TTM)28.00K
Net Income(TTM)-12.39M
Analysts82.5
Price Target3.32 (308.72%)
Short Float %4.03%
Short Ratio3.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend23.88
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.47%
Min EPS beat(2)1.96%
Max EPS beat(2)22.97%
EPS beat(4)4
Avg EPS beat(4)29.17%
Min EPS beat(4)1.96%
Max EPS beat(4)57.11%
EPS beat(8)7
Avg EPS beat(8)24.45%
EPS beat(12)10
Avg EPS beat(12)20.71%
EPS beat(16)14
Avg EPS beat(16)19.45%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-22%
PT rev (3m)-22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)46.67%
EPS NY rev (1m)0%
EPS NY rev (3m)30%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1352.19
P/FCF N/A
P/OCF N/A
P/B 1.97
P/tB N/A
EV/EBITDA 0.52
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-31.11
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0
BVpS0.41
TBVpS-5.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40.3%
ROE -64.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12540700%
FCFM N/A
ROA(3y)-24.13%
ROA(5y)-35.67%
ROE(3y)-32.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 130.74%
Cap/Sales 5136790%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.83
Quick Ratio -1.3
Altman-Z -20
F-Score5
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y30%
EPS Next 2Y14.02%
EPS Next 3Y6.27%
EPS Next 5Y20.3%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7496.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.06%
OCF growth 3YN/A
OCF growth 5YN/A

TALPHERA INC / TLPH FAQ

What is the fundamental rating for TLPH stock?

ChartMill assigns a fundamental rating of 2 / 10 to TLPH.


What is the valuation status of TALPHERA INC (TLPH) stock?

ChartMill assigns a valuation rating of 1 / 10 to TALPHERA INC (TLPH). This can be considered as Overvalued.


How profitable is TALPHERA INC (TLPH) stock?

TALPHERA INC (TLPH) has a profitability rating of 1 / 10.


What is the financial health of TALPHERA INC (TLPH) stock?

The financial health rating of TALPHERA INC (TLPH) is 5 / 10.